A Study to Evaluate HB0034 in Healthy Chinese Adult Participants

NCT06716151 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HB0034
DRUG: HB0034 matching placebo

Sponsor

Shanghai Huaota Biopharmaceutical Co., Ltd.